ArticleFrontiers in cardiovascular medicine2025
A multimodal AI-driven framework for cardiovascular screening and risk assessment in diverse athletic populations: innovations in sports cardiology.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The increasing complexity of athlete cardiovascular risk profiles, coupled with evolving demands in pre-participation screening, necessitates robust, interpretable, and physiologically grounded assessment tools. Current approaches to cardiovascular screening, typically reliant on binary ECG interpretations or risk scores, often fall short in accurately differentiating benign athletic heart adaptations from early-stage pathological conditions, particularly across diverse athletic populations. These conventional systems are limited by their inability to capture multi-modal clinical inputs, susceptibility to diagnostic ambiguity, and lack of structured integration between exertional physiology and latent cardiovascular risk. Methods: To address these challenges, we propose a novel AI-driven framework that incorporates two key methodological innovations: CardioSpectra, a structured sparse inference model, and Risk-Stratified Exertional Embedding (RSEE), a domain-specific representation learning strategy. CardioSpectra formulates athlete profiles as multivariate probabilistic entities across latent diagnostic states, using sparsity-aware inference to generate interpretable risk predictions while optimizing a sensitivity-specificity trade-off tailored to clinical priorities. RSEE projects heterogeneous input data into an exertion-conditioned latent space, aligning model predictions with observed physiological variance and mitigating false positives by explicitly modeling the overlap between athletic remodeling and subclinical pathology. Results and Discussion: Experimental evaluation across varied athlete cohorts demonstrates superior performance in risk stratification accuracy, diagnostic plausibility, and model transparency compared to traditional screening algorithms. This multimodal framework not only advances the fidelity of cardiovascular screening in athletic populations but also establishes a scalable and principled foundation for integrating computational diagnostics with real-world cardiological assessment practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.